Trial Profile
A randomised controlled trial of eicosapentaenoic acid (EPA) and/or aspirin for colorectal adenoma (or polyp) prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod (Systematic Evaluation of Aspirin and Fish Oil) polyp prevention trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2023
Price :
$35
*
At a glance
- Drugs Eicosapentaenoic acid (Primary) ; Aspirin
- Indications Adenoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms seAFOod Polyp Prevention Trial
- 30 Jul 2023 Results published in the Alimentary Pharmacology and Therapeutics
- 30 Nov 2018 Results published in the Lancet
- 24 Oct 2018 Results presented at the 26th United European Gastroenterology Week